Founded in 1941 in Tokyo as an optical glass production plant, Hoya is one of the largest eyeglass lens manufacturers in the world... Show more
HOCPF moved above its 50-day moving average on January 27, 2026 date and that indicates a change from a downward trend to an upward trend. In of 36 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HOCPF just turned positive on January 07, 2026. Looking at past instances where HOCPF's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for HOCPF crossed bullishly above the 50-day moving average on January 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
HOCPF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day RSI Indicator for HOCPF moved out of overbought territory on January 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Momentum Indicator moved below the 0 level on February 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HOCPF as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Aroon Indicator for HOCPF entered a downward trend on January 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.123) is normal, around the industry mean (11.448). P/E Ratio (40.598) is within average values for comparable stocks, (149.436). Projected Growth (PEG Ratio) (2.482) is also within normal values, averaging (2.437). Dividend Yield (0.010) settles around the average of (0.017) among similar stocks. P/S Ratio (9.328) is also within normal values, averaging (111.001).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HOCPF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HOCPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry PharmaceuticalsOther
A.I.dvisor tells us that HOCPF and AXGN have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HOCPF and AXGN's prices will move in lockstep.
| Ticker / NAME | Correlation To HOCPF | 1D Price Change % | ||
|---|---|---|---|---|
| HOCPF | 100% | N/A | ||
| AXGN - HOCPF | 25% Poorly correlated | +0.49% | ||
| HOCPY - HOCPF | 25% Poorly correlated | +0.20% | ||
| SHWGY - HOCPF | 24% Poorly correlated | N/A | ||
| TIVC - HOCPF | 20% Poorly correlated | -7.56% | ||
| FZMD - HOCPF | 4% Poorly correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To HOCPF | 1D Price Change % |
|---|---|---|
| HOCPF | 100% | N/A |
| Pharmaceuticals: Other industry (107 stocks) | 16% Poorly correlated | -0.87% |
| Pharmaceuticals industry (380 stocks) | 10% Poorly correlated | +27.23% |